C91.61
Prolymphocytic leukemia of T-cell type, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Prolymphocytic leukemia of T-cell type (PPLL T-cell) is a rare form of blood cancer characterized by the abnormal growth of T-lymphocytes, a type of white blood cell involved in the immune response. When the disease is in remission, symptoms have significantly decreased or disappeared, often following treatment. This condition is classified under ICD-10 code C91.61. Remission indicates a period during which the disease is under control, but it does not necessarily mean the cancer has been cured. Regular monitoring and follow-up care are essential for managing this condition.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell development Exposure to certain chemicals or radiation Underlying immune system disorders Previous history of other lymphoid cancers Unknown factors in many cases
Key Symptoms: Persistent or recurrent swollen lymph nodes Unexplained weight loss Fever or night sweats Fatigue or weakness Unintentional weight loss Frequent infections due to compromised immunity Enlarged spleen or liver Skin rashes or ulcers in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of blood tests, bone marrow biopsies, and imaging studies. These help to identify abnormal T-lymphocytes and assess the extent of disease. Specific tests may include:
Treatment Protocols: While treatment options vary based on individual health status and disease progression, management may include:
Clinical Advice & FAQs
Billing Guidance
Is C91.61 a billable ICD-10 code?
Yes, C91.61 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C91.61?
Clinical documentation must specify the nature of Prolymphocytic leukemia of T-cell type, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference